Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia

Acta Urologica Japonica

Volumn 49, Issue 8, 2003, Pages 445-449

  Sugino, Yoshio ^a   Fukuzawa, Shigeki ^a   Takeuchi, Hideo ^a   Taki, Youji ^a   Hashimura, Takayuki ^a   Soeda, Tomoki ^a   Araki, Isao ^a  

^a NONE

Author keywords

Alpha 1 blocker; Benign prostatic hyperplasia; Naftopidil; Nocturia; Pollakisuria

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; NAFTOPIDIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG EFFECT; FLOW RATE; HUMAN; MALE; MICTURITION; NOCTURIA; POLLAKISURIA; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SCORING SYSTEM; SYMPTOMATOLOGY; URINE VOLUME;

EID: 0141591511     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jpn J Geriat 37: 739-743, 2000
2. Malloy BJ, Price DT, Price RR, et al.: Alpha 1-adrenergic receptor subtypes in human detrusor. J Urol 160: 937, 1998
3. Hampel C, Dolber PC, Savic SL, et al.: Changes in α1 adrenergic receptor (AR) subtype gene expression during bladder outlet obstruction of rats. J Urol 163: 228, 2000
4. Nomiya M, Shishido K, Yamaguchi O, et al.: A quantitative analysis of mRNA expression of alpha-1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170(2 pt 1): 649-653, 2003
5. Yoshiyama M, Yamamoto T, de Groat W, et al.: Role of spinal α1-adrenergic mechanisms in the control of lower urinary tract in the rat. Brain Res 882: 36-44, 2000
6. Sugaya K, Nishijima, S, Ogawa Y, et al.: Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats. Neurosci Lett 328: 74-76, 2002
7. 1-adrenoceptor blocker, Rinsyou Iyaku 8: 25-43, 1992
8. Michel MC, Neumann HG, Goepel M, et al.: Does the time of administration (morning or evening) affect the tolerability or efficacy of tamusulosin? BJU Int 87: 31-34, 2001